Earlier this fall, the Company announced a joint working agreement to integrate a major manufacturer’s devices with its HealthTab™ data reporting platform for deployment in Canada, resulting in new testing capabilities, including COVID-19 molecular PCR results via the ID Now™.  VANCOUVER, BRITISH COLUMBIA – December 14, 2020 – AVRICORE HEALTH

The Company welcomes CTO Rodger Seccombe, co-creator of HealthTab to the Board. Thanks, Bobby Rai for his service and leadership on the Board of Directors and as President he takes advisory role. VANCOUVER, BC – December 10th, 2020 – Avricore Health Inc.(TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) announces changes

VANCOUVER, BC – (GLOBE NEWSWIRE) – December 3rd, 2020 – Avricore Health Inc.(TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing its real-time reporting HealthTabÔ systems in Oak Medical Art’s community pharmacy locations, bringing advanced point of care testing to Canada’s North for the first time. “HealthTab

VANCOUVER, British Columbia, Nov. 24, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on Friday, November 13, by Avricore Health Inc. (TSXV: AVCR), the units issued figure was meant to be 6,260,000, not 6,360,000. The corrected release follows: AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it has

Avricore Health and the OPA expand their partnership to promote HealthTab™ to pharmacies conducting COVID-19 testing and government for real-time reporting of test results for better community safety. VANCOUVER, BC – (GLOBE NEWSWIRE) – November 23, 2020 – Avricore Health Inc. (TSXV: AVCR) and the Ontario Pharmacists Association (OPA) are pleased to announce the expansion of

Vancouver, British Columbia – October 14, 2020 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces a non-brokered private placement of up to 15,000,000 units (“Units“) at a price of $0.10 per unit for gross proceeds of $1,500,000. (the “Private Placement“). The proceeds will be used for general

Avricore Health’s HealthTab™ Achieves Critical Milestones in Connecting New Testing Device   VANCOUVER, British Columbia, October 7th, 2020 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore” or the “Company“) has achieved significant milestones in completing due diligence, technical reviews, and initial connectivity between its real-time data reporting platform, HealthTab™

HealthTab™ Integrating New Device to Add HbA1c Blood Glucose Testing to Its Real-Time Data Reporting System VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore” or the “Company“) is pleased to announce the signing of a Letter of Intent (LOI) with a prominent,

Avricore Health’s HealthTab to Enable Real Time Reporting of COVID-19 Results in Pharmacy   VANCOUVER, British Columbia, September 9th, 2020 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore” or the “Company”) a leader in pharmacy-based point-of- care testing solutions, plans to offer its HealthTab system as a

VANCOUVER, BRITISH COLUMBIA – July 2, 2020) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to announce that it has entered into  shares for debt agreements, to satisfy an aggregate of  $126,949 of the Company’s outstanding debts. The Company has reached agreements with certain of its